Advanced search
Publication Cover
Annals of Medicine Volume 54, 2022 - Issue 1
Submit an article Journal homepage
1,383
Views
0
CrossRef citations to date
0
Altmetric
Immunology

Adverse reactions in venom immunotherapy protocols: conventional versus ultra-rush

Ali SelcukDepartment of Immunology and Allergy, Gulhane Training and Research Hospital, Ankara, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4089-7564View further author information
ORCID Icon,
Abdullah BaysanDepartment of Immunology and Allergy, Gulhane Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0003-1538-4732View further author information
ORCID Icon,
Sait YesillikDepartment of Immunology and Allergy, Gulhane Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0003-1160-1381View further author information
ORCID Icon,
Fevzi DemirelDepartment of Immunology and Allergy, Gulhane Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0002-9711-6821View further author information
ORCID Icon,
Ozgur KartalDepartment of Immunology and Allergy, Gulhane Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0002-6666-581XView further author information
ORCID Icon,
Mustafa GulecDepartment of Immunology and Allergy, Gulhane Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0002-0157-2612View further author information
ORCID Icon,
Ugur MusabakDepartment of Immunology and Allergy, Gulhane Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0003-1511-7634View further author information
ORCID Icon &
Osman SenerDepartment of Immunology and Allergy, Gulhane Training and Research Hospital, Ankara, TurkeyORCID Iconhttps://orcid.org/0000-0002-8174-2895View further author information
ORCID Icon show all
Pages 2320-2324 | Received 18 Oct 2021, Accepted 09 Aug 2022, Published online: 16 Sep 2022

References

  • Sturm GJ, Varga EM, Roberts G, et al. EAACI guidelines on allergen immunotherapy: hymenoptera venom allergy. Allergy. 2018;73(4):744–764.
  • Biló BM, Rueff F, Mosbech H, et al.; EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of hymenoptera venom allergy. Allergy. 2005;60(11):1339–1349.
  • Worm M, Moneret‐Vautrin A, Scherer K, et al. First European data from the network of severe allergic reactions (NORA). Allergy. 2014;69(10):1397–1404.
  • Bilò MB, Tontini C, Martini M, et al. Clinical aspects of hymenoptera venom allergy and venom immunotherapy. Eur Ann Allergy Clin Immunol. 2019;51(6):244–258.
  • Birnbaum J, Ramadour M, Magnan A, et al. Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors. Clin Exp Allergy. 2003;33(1):58–64.
  • Bożek A, Kołodziejczyk K. Safety of specific immunotherapy using an ultra-rush induction regimen in bee and wasp allergy. Hum Vaccin Immunother. 2018;14(2):288–291.
  • Nittner-Marszalska M, Cichocka-Jarosz E, Małaczyńska T, et al. Safety of ultrarush venom ımmunotherapy: comparison between children and adults. J Investig Allergol Clin Immunol. 2016;26(1):40–47.
  • Rueff F, Przybilla B, Bilo MB, et al. Predictors of side effects during the buildup phase of venom immunotherapy for hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol. 2010;126(1):105–111.
  • Boyle RJ, Elremeli M, Hockenhull J, et al. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev. 2012;10:CD008838.
  • Golden DBK, Demain J, Freeman T, et al. Stinging insect hypersensitivity: a practice parameter update 2016. Ann Allergy Asthma Immunol. 2017;118(1):28–54.
  • Mueller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res. 1966;3(4):331–333.
  • Sturm GJ, Arzt-Gradwohl L, Varga EM. Medical algorithms: diagnosis and treatment of hymenoptera venom allergy. Allergy. 2019;74(10):2016–2018.
  • Mosbech H, Muller U. Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology. Allergy. 2000;55(11):1005–1010.
  • Lockey RF, Turkeltaub PC, Olive ES, et al. The hymenoptera venom study. III: safety of venom immunotherapy. J Allergy Clin Immunol. 1990;86(5):775–780.
  • Roll A, Hofbauer G, Ballmer-Weber BK, et al. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy. J Investig Allergol Clin Immunol. 2006;16(2):79–85.
  • Korošec P, Žiberna K, Šilar M, et al. Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy. Clin Exp Allergy. 2015;45(10):1579–1589.
  • Sturm G, Kranke B, Rudolph C, et al. Rush hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients. J Allergy Clin Immunol. 2002;110(6):928–933.
  • Roumana A, Pitsios C, Vartholomaios S, et al. The safety of initiating hymenoptera immunotherapy at 1 microg of venom extract. J Allergy Clin Immunol. 2009;124(2):379–381.
  • Cosme J, Spínola-Santos A, Pereira-Santos MC, et al. Venom ımmunotherapy: a 20-year experience with an ultra-rush protocol (210-min). Eur Ann Allergy Clin Immunol. 2019;51(3):122–128.
  • Bilò MB, Antonicelli L, Bonifazi F. Purified vs. nonpurified venom immunotherapy. Curr Opin Allergy Clin Immunol. 2010;10(4):330–336.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.